本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Arbutus Biopharma Corporation

5.12
0.0000
盤前5.120.00000.00%04:50 EDT
成交量:185.00萬
成交額:948.91萬
市值:10.08億
市盈率:6.48
高:5.18
開:5.17
低:5.11
收:5.12
52周最高:5.45
52周最低:3.50
股本:1.97億
流通股本:1.23億
量比:0.43
換手率:1.50%
股息:- -
股息率:- -
每股收益(TTM):0.7896
每股收益(LYR):-0.1748
淨資產收益率:89.58%
總資產收益率:48.84%
市淨率:3.90
市盈率(LYR):-29.28

資料載入中...

2019/08/09

員工持股計劃

Securities to be offered to employees in employee benefit plans
2019/08/09

重要事件披露

Current report, items 8.01 and 9.01
2019/08/05

季度報告

Quarterly report [Sections 13 or 15(d)]
2019/08/05

重要事件披露

Current report, items 2.02 and 9.01
2019/07/18

重要事件披露

Current report, item 8.01
2019/07/17

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/07/17

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/07/16

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/07/15

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/07/15

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/07/12

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/07/12

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/07/12

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/07/12

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/07/12

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/07/12

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/07/12

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/07/12

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/07/12

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/07/03

重要事件披露

Current report, item 1.01